652 related articles for article (PubMed ID: 16684811)
1. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
2. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of irritability in pervasive developmental disorders.
Stigler KA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
[TBL] [Abstract][Full Text] [Related]
5. Risperidone: a potential treatment for autism.
Posey DJ; McDougle CJ
Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
[TBL] [Abstract][Full Text] [Related]
6. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
[TBL] [Abstract][Full Text] [Related]
7. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
8. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
9. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
[TBL] [Abstract][Full Text] [Related]
10. Open trial of risperidone in 24 young children with pervasive developmental disorders.
Masi G; Cosenza A; Mucci M; Brovedani P
J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
[TBL] [Abstract][Full Text] [Related]
11. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
Capone GT; Goyal P; Grados M; Smith B; Kammann H
J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
Findling RL
J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
[TBL] [Abstract][Full Text] [Related]
13. Risperidone in children with autism and serious behavioral problems.
McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
[TBL] [Abstract][Full Text] [Related]
14. Risperidone use in the treatment of behavioral symptoms in children with autism.
West L; Waldrop J
Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
[TBL] [Abstract][Full Text] [Related]
15. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
Lindsay RL; Eugene Arnold L; Aman MG; Vitiello B; Posey DJ; McDougle CJ; Scahill L; Pachler M; McCracken JT; Tierney E; Bozzolo D
J Intellect Dev Disabil; 2006 Dec; 31(4):204-9. PubMed ID: 17178532
[TBL] [Abstract][Full Text] [Related]
16. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
Arnold LE; Vitiello B; McDougle C; Scahill L; Shah B; Gonzalez NM; Chuang S; Davies M; Hollway J; Aman MG; Cronin P; Koenig K; Kohn AE; McMahon DJ; Tierney E
J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1443-50. PubMed ID: 14627879
[TBL] [Abstract][Full Text] [Related]
17. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis.
Sharma A; Shaw SR
J Pediatr Health Care; 2012; 26(4):291-9. PubMed ID: 22726714
[TBL] [Abstract][Full Text] [Related]
19. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
[TBL] [Abstract][Full Text] [Related]
20. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
